Northwest Investment Counselors, LLC Edwards Lifesciences Corp Transaction History

Northwest Investment Counselors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$72.54 - $95.56 $10,300 - $13,569	142 New	142 $13,000
Q3 2023 Oct 12, 2023	BUY	$69.28 - $93.38 $3,602 - $4,855	52 Added 5.15%	1,061 $73,000
Q1 2023 Apr 17, 2023	SELL	$74.26 - $84.51 $9,728 - $11,070	-131 Reduced 11.49%	1,009 $83,000
Q4 2022 Jan 18, 2023	BUY	$68.3 - $87.44 $71,715 - $91,812	1,050 Added 1166.67%	1,140 $0
Q3 2022 Oct 28, 2022	SELL	$82.37 - $107.29 $10,131 - $13,196	-123 Reduced 57.75%	90 $7,000
Q1 2022 Apr 18, 2022	SELL	$101.96 - $128.34 $2,141 - $2,695	-21 Reduced 8.97%	213 $25,000
Q4 2021 Jan 26, 2022	BUY	$106.37 - $130.68 $24,890 - $30,579	234 New	234 $30,000
Q2 2021 Jul 22, 2021	SELL	$83.84 - $104.76 $19,618 - $24,513	-234 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$78.68 - $90.67 $18,411 - $21,216	234 New	234 $20,000
Q4 2020 Jan 26, 2021	SELL	$71.69 - $91.23 $16,775 - $21,347	-234 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$67.19 - $87.44 $15,722 - $20,460	234 New	234 $19,000
Q4 2019 Jan 27, 2020	SELL	$71.7 - $82.09 $1,577 - $1,805	-22 Closed	0 $0
Q3 2019 Oct 30, 2019	BUY	$61.55 - $75.43 $1,354 - $1,659	22 New	22 $5,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

Stay updated on Northwest Investment Counselors, LLC with notifications on news.